Found 2 articles for: "FAERS"
Cutaneous Adverse Events Associated With GLP-1 Receptor Agonists: A FAERS Database Analysis From 2018-2024
January 2026 | Volume 25 | Issue 1 | Original Article | 11 | Copyright © January 2026
Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for conditions beyond type 2 diabetes, including psoriasis and hidradenitis suppurat...
Read MoreThe Practical Side Effects Experienced in Patients Treated With Medications Approved for Melanoma
May 2025 | Volume 24 | Issue 5 | Features | 539 | Copyright © May 2025
Background: Melanoma continues to remain one of the most feared malignancies among patients and dermatologists. Significant strides have been made in expanding the treatment arse...
Read More
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.